Skip to main content

An article from

Cover

Published Jan. 2, 2008

By PharmaVoice Team

Medicare Part D Marketing Opportunities and Challenges In the Lab with Prof. Paul Herrling Journal Advertising The Pediatric Drug Market March 2006 www.pharmavoice.com Volume 6, Issue 3 The forum for the industry executive

Filed Under: Commercialization

PharmaVoice stories and insights delivered to your inbox

Get the free daily newsletter read by industry leaders

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Stock via Getty Images

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

More drugs surpassed $10 billion in revenue last year than ever before.

By Amy Baxter • June 23, 2025

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Playbook
How to Optimize Pharma Packaging for Brand Impact & Logistics Custom content for Cardinal Health
Webinar - on demand
Maximize Clinical Development Efficiency With An Outsourcing Strategy Custom content for PPD FSP solutions
Trendline
The latest advances in cancer research Supported by Quest Diagnostics

PharmaVoice stories and insights delivered to your inbox

Get the free daily newsletter read by industry leaders

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Read next

Stock via Getty Images

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

More drugs surpassed $10 billion in revenue last year than ever before.

By Amy Baxter • June 23, 2025

Latest in Commercialization

Biogen scores Cannes Festival win with dark humored campaign

By Alexandra Pecci
Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

By Amy Baxter
Is DTC pharma advertising coming to an end?

By Amy Baxter

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Get PharmaVoice in your inbox

The free newsletter covering the top industry headlines

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.